DJIA 16,897.08 106.89 0.64%
NASDAQ 4,789.70 41.33 0.87%
S&P 500 1,992.70 12.78 0.65%
market minute promo

Gilead Sciences (NASDAQ: GILD)

100.30 2.76 (2.83%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

GILD $100.05 2.57%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $97.99
Previous Close $97.54
Daily Range $97.50 - $100.76
52-Week Range $85.95 - $123.37
Market Cap $147.2B
P/E Ratio 10.26
Dividend (Yield) $1.72 (1.8%)
Ex-Dividend Date
Dividend Pay Date
Volume 8,788,564
Average Daily Volume 12,945,454
Current FY EPS $11.99




Drug Makers

Gilead Sciences (GILD) Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website:

News & Commentary Rss Feed

Biotech's Bloodbath Is Ridiculous; Here's Why

Biotech stocks have been getting pummeled in the last two months. A deeper look at the root cause of this sell-off, though, shows that it's probably unwarranted, making now a great time to buy these stocks on the cheap.

Stock Market News for October 07, 2015

Only 9% Of Nasdaq Biotechnology Stocks Are Good Value: I Am Shorting The Sector And Watching Gilead

Health Care Sector Update for 10/07/2015: CTRV,AVXL,ADPT

3 Drugs Stocks Moving The Industry Upward

Top 2 Trade Alert Ideas October 5: ChemoCentryx Undervalued, Spark Therapeutics Rally, HBV Market

Gilead (GILD): Improving Lives, Improving Stock

Merck's (MRK) All-Oral Ribavirin-Free HCV Data Published

Biotech Bears Spark Good Vibes For These ETFs

Social Media Beat: The Three Gs -- GE, Google And Gilead

See More GILD News...

GILD's Top Competitors

GILD $100.30 (2.83%)
Current stock: GILD
AMGN $147.48 (4.43%)
Current stock: AMGN
CELG $117.68 (4.89%)
Current stock: CELG
$0.00 (0.00%)
Current stock: